Literature DB >> 2521553

Activation of pro-urokinase by plasmin: non-Michaelian kinetics indicates a mechanism of negative cooperativity.

M F Scully1, V Ellis, Y Watahiki, V V Kakkar.   

Abstract

Enzyme kinetic plots relating the initial rate of activation of pro-urokinase to urokinase by plasmin, according to the concentration of substrate, were smooth downward curves and indicated that an apparent decrease in binding affinity occurred with increase in the concentration of pro-urokinase. Such nonlinear plots were obtained with plasmin 1 and also plasmin 2. Over sections of each curve it was possible to estimate apparent kinetic constants. At the uppermost concentrations of substrate tested, these were Km 2.9 microM and kcat 35.5 min-1 for plasmin 1, and at the lowermost concentrations, Km 9.5 nM and kcat 2.0 min-1. Linear plots were obtained when the single proteolytic cleavage was made by K5-plasmin or undegraded plasmin in the presence of 1.0 mM 6-aminohexanoic acid (6-AHa). Constants were estimated for catalysis of this reaction by K5 plasmin to be Km 6.0 microM and kcat 38 min-1 (r = 0.987). The catalytic efficiency of plasmin, at the lowermost concentrations of pro-urokinase tested, was therefore 33-fold higher than that of K5-plasmin. Plotting of data for the cleavage of pro-urokinase by plasmin 1 (in the absence of 6-AHa) according to the model of Hill, gave a slope of 0.5 at the lowermost concentrations of pro-urokinase increasing to 1.0 at higher concentrations (greater than 0.3 microM); such a profile is characteristic of negative cooperativity. The rates of formation of plasmin and urokinase in a mixture containing a low concentration of plasminogen and pro-urokinase were measured and compared to those predicted by a computer program designed to calculate theoretical rates using available kinetic data. The observed rates of generation of both plasmin and urokinase coincided to those predicted from the negative cooperativity model. The mechanism of the negative cooperativity may reside in a conformational change induced by binding of pro-urokinase to the kringle structure of plasmin. This property may be of significance in controlling the fibrinolytic properties of the urokinase-type plasminogen activator system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521553     DOI: 10.1016/0003-9861(89)90311-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.

Authors:  C A Goodwin; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase.

Authors:  S Namiranian; Y Naito; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

3.  Inhibition of plasmin by fibrinogen.

Authors:  A A Higazi; M Mayer
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

4.  Regulation of fibrinolysis by non-esterified fatty acids.

Authors:  A A Higazi; R Aziza; A A Samara; M Mayer
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

5.  Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.

Authors:  G A de Munk; E Groeneveld; D C Rijken
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

6.  Stimulation of plasmin activity by oleic acid.

Authors:  A A Higazi; Z Finci-Yeheskel; A A Samara; R Aziza; M Mayer
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

7.  Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.

Authors:  V Ellis; K Danø
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

Review 8.  Novel thrombolytic agents.

Authors:  M Verstraete; H R Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.